Structure-based Design of Dual Small-Molecule Inhibitors of Mdm2/Mdmx for Efficiently Reactivating P53 in Cancer Cells

被引：0
|
作者：
Su, Zhengding [1 ,2 ]
Duda, David [2 ]
Qin, Lingyun [1 ]
Chen, Yao [1 ]
Zhang, Huashan [1 ]
Wang, Weiping [1 ]
Schulman, Brenda [2 ]
机构：
[1] Hubei Univ Technol, Wuhan, Hubei, Peoples R China
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
PROTEIN SCIENCE | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
10-69
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [1] The Structure-Based Design of Mdm2/Mdmx-p53 Inhibitors Gets Serious
    Popowicz, Grzegorz M.
    Doemling, Alexander
    Holak, Tad A.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (12) : 2680 - 2688
  • [2] Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX
    Phan, Jason
    Li, Zhenyu
    Kasprzak, Agnieszka
    Li, Baozong
    Sebti, Said
    Guida, Wayne
    Schoenbrunn, Ernst
    Chen, Jiandong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (03) : 2174 - 2183
  • [3] Bicyclic stapled peptides based on p53 as dual inhibitors for the interactions of p53 with MDM2 and MDMX
    Li, Hongjin
    Chen, Xiangyan
    Wu, Minghao
    Song, Panpan
    Zhao, Xia
    CHINESE CHEMICAL LETTERS, 2022, 33 (03) : 1254 - 1258
  • [4] Bicyclic stapled peptides based on p53 as dual inhibitors for the interactions of p53 with MDM2 and MDMX
    Hongjin Li
    Xiangyan Chen
    Minghao Wu
    Panpan Song
    Xia Zhao
    ChineseChemicalLetters, 2022, 33 (03) : 1254 - 1258
  • [5] Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
    Haohao Zhu
    Hui Gao
    Yingying Ji
    Qin Zhou
    Zhiqiang Du
    Lin Tian
    Ying Jiang
    Kun Yao
    Zhenhe Zhou
    Journal of Hematology & Oncology, 15
  • [6] Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels
    Tudhope, Sue
    Zhao, Yan
    Wittner, Anita
    Wilmore, Elaine
    Bertoli, Annalisa
    Adhikari, Santosh
    Harnor, Suzannah J.
    Del Bello, Fabio
    Piergentili, Alessandro
    Lunec, John
    Hardcastle, Ian R.
    Griffin, Roger J.
    Golding, Bernard R.
    Cano, Celine
    Newell, David R.
    Wedge, Stephen R.
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors
    Ivanenkov, Yan A.
    Vasilevski, Sergei V.
    Beloglazkina, Elena K.
    Kukushkin, Maksim E.
    Machulkin, Alexey E.
    Veselov, Mark S.
    Chufarova, Nina V.
    Chernyaginab, Elizaveta S.
    Vanzcool, Anton S.
    Zyk, Nikolay V.
    Skvortsov, Dmitry A.
    Khutornenko, Anastasia A.
    Rusanov, Alexander L.
    Tonevitsky, Alexander G.
    Dontsova, Olga A.
    Majouga, Alexander G.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (02) : 404 - 409
  • [8] Small molecule inhibitors of p53/MDM2 interaction
    Fotouhi, N
    Graves, B
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 159 - 165
  • [9] Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
    Shen, Hong
    Maki, Carl G.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (06) : 560 - 568
  • [10] MDM2, MDMX and p53 in oncogenesis and cancer therapy
    Mark Wade
    Yao-Cheng Li
    Geoffrey M. Wahl
    Nature Reviews Cancer, 2013, 13 : 83 - 96
12345